Global Shingles Vaccine Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Shingles Vaccine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Shingles Vaccine Market Size by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Zostavax
  • 1.2.3 Shingrix
• 1.3 Market by Application
  • 1.3.1 Global Shingles Vaccine Market Size by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Under 50 Years Old
  • 1.3.3 50-60 Years Old
  • 1.3.4 60-70 Years Old
  • 1.3.5 Above 70 Years Old
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Shingles Vaccine Production

• 2.1 Global Shingles Vaccine Production Capacity (2017-2028)
• 2.2 Global Shingles Vaccine Production by Region: 2017 VS 2021 VS 2028
• 2.3 Global Shingles Vaccine Production by Region
  • 2.3.1 Global Shingles Vaccine Historic Production by Region (2017-2022)
  • 2.3.2 Global Shingles Vaccine Forecasted Production by Region (2023-2028)
• 2.4 North America
• 2.5 Europe
• 2.6 China
• 2.7 Japan

3 Global Shingles Vaccine Sales in Volume & Value Estimates and Forecasts

• 3.1 Global Shingles Vaccine Sales Estimates and Forecasts 2017-2028
• 3.2 Global Shingles Vaccine Revenue Estimates and Forecasts 2017-2028
• 3.3 Global Shingles Vaccine Revenue by Region: 2017 VS 2021 VS 2028
• 3.4 Global Shingles Vaccine Sales by Region
  • 3.4.1 Global Shingles Vaccine Sales by Region (2017-2022)
  • 3.4.2 Global Sales Shingles Vaccine by Region (2023-2028)
• 3.5 Global Shingles Vaccine Revenue by Region
  • 3.5.1 Global Shingles Vaccine Revenue by Region (2017-2022)
  • 3.5.2 Global Shingles Vaccine Revenue by Region (2023-2028)
• 3.6 North America
• 3.7 Europe
• 3.8 Asia-Pacific
• 3.9 Latin America
• 3.10 Middle East & Africa

4 Competition by Manufactures

• 4.1 Global Shingles Vaccine Production Capacity by Manufacturers
• 4.2 Global Shingles Vaccine Sales by Manufacturers
  • 4.2.1 Global Shingles Vaccine Sales by Manufacturers (2017-2022)
  • 4.2.2 Global Shingles Vaccine Sales Market Share by Manufacturers (2017-2022)
  • 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Shingles Vaccine in 2021
• 4.3 Global Shingles Vaccine Revenue by Manufacturers
  • 4.3.1 Global Shingles Vaccine Revenue by Manufacturers (2017-2022)
  • 4.3.2 Global Shingles Vaccine Revenue Market Share by Manufacturers (2017-2022)
  • 4.3.3 Global Top 10 and Top 5 Companies by Shingles Vaccine Revenue in 2021
• 4.4 Global Shingles Vaccine Sales Price by Manufacturers
• 4.5 Analysis of Competitive Landscape
  • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 4.5.2 Global Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.5.3 Global Shingles Vaccine Manufacturers Geographical Distribution
• 4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

• 5.1 Global Shingles Vaccine Sales by Type
  • 5.1.1 Global Shingles Vaccine Historical Sales by Type (2017-2022)
  • 5.1.2 Global Shingles Vaccine Forecasted Sales by Type (2023-2028)
  • 5.1.3 Global Shingles Vaccine Sales Market Share by Type (2017-2028)
• 5.2 Global Shingles Vaccine Revenue by Type
  • 5.2.1 Global Shingles Vaccine Historical Revenue by Type (2017-2022)
  • 5.2.2 Global Shingles Vaccine Forecasted Revenue by Type (2023-2028)
  • 5.2.3 Global Shingles Vaccine Revenue Market Share by Type (2017-2028)
• 5.3 Global Shingles Vaccine Price by Type
  • 5.3.1 Global Shingles Vaccine Price by Type (2017-2022)
  • 5.3.2 Global Shingles Vaccine Price Forecast by Type (2023-2028)

6 Market Size by Application

• 6.1 Global Shingles Vaccine Sales by Application
  • 6.1.1 Global Shingles Vaccine Historical Sales by Application (2017-2022)
  • 6.1.2 Global Shingles Vaccine Forecasted Sales by Application (2023-2028)
  • 6.1.3 Global Shingles Vaccine Sales Market Share by Application (2017-2028)
• 6.2 Global Shingles Vaccine Revenue by Application
  • 6.2.1 Global Shingles Vaccine Historical Revenue by Application (2017-2022)
  • 6.2.2 Global Shingles Vaccine Forecasted Revenue by Application (2023-2028)
  • 6.2.3 Global Shingles Vaccine Revenue Market Share by Application (2017-2028)
• 6.3 Global Shingles Vaccine Price by Application
  • 6.3.1 Global Shingles Vaccine Price by Application (2017-2022)
  • 6.3.2 Global Shingles Vaccine Price Forecast by Application (2023-2028)

7 North America

• 7.1 North America Shingles Vaccine Market Size by Type
  • 7.1.1 North America Shingles Vaccine Sales by Type (2017-2028)
  • 7.1.2 North America Shingles Vaccine Revenue by Type (2017-2028)
• 7.2 North America Shingles Vaccine Market Size by Application
  • 7.2.1 North America Shingles Vaccine Sales by Application (2017-2028)
  • 7.2.2 North America Shingles Vaccine Revenue by Application (2017-2028)
• 7.3 North America Shingles Vaccine Sales by Country
  • 7.3.1 North America Shingles Vaccine Sales by Country (2017-2028)
  • 7.3.2 North America Shingles Vaccine Revenue by Country (2017-2028)
  • 7.3.3 U.S.
  • 7.3.4 Canada

8 Europe

• 8.1 Europe Shingles Vaccine Market Size by Type
  • 8.1.1 Europe Shingles Vaccine Sales by Type (2017-2028)
  • 8.1.2 Europe Shingles Vaccine Revenue by Type (2017-2028)
• 8.2 Europe Shingles Vaccine Market Size by Application
  • 8.2.1 Europe Shingles Vaccine Sales by Application (2017-2028)
  • 8.2.2 Europe Shingles Vaccine Revenue by Application (2017-2028)
• 8.3 Europe Shingles Vaccine Sales by Country
  • 8.3.1 Europe Shingles Vaccine Sales by Country (2017-2028)
  • 8.3.2 Europe Shingles Vaccine Revenue by Country (2017-2028)
  • 8.3.3 Germany
  • 8.3.4 France
  • 8.3.5 U.K.
  • 8.3.6 Italy
  • 8.3.7 Russia

9 Asia Pacific

• 9.1 Asia Pacific Shingles Vaccine Market Size by Type
  • 9.1.1 Asia Pacific Shingles Vaccine Sales by Type (2017-2028)
  • 9.1.2 Asia Pacific Shingles Vaccine Revenue by Type (2017-2028)
• 9.2 Asia Pacific Shingles Vaccine Market Size by Application
  • 9.2.1 Asia Pacific Shingles Vaccine Sales by Application (2017-2028)
  • 9.2.2 Asia Pacific Shingles Vaccine Revenue by Application (2017-2028)
• 9.3 Asia Pacific Shingles Vaccine Sales by Region
  • 9.3.1 Asia Pacific Shingles Vaccine Sales by Region (2017-2028)
  • 9.3.2 Asia Pacific Shingles Vaccine Revenue by Region (2017-2028)
  • 9.3.3 China
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 India
  • 9.3.7 Australia
  • 9.3.8 Taiwan
  • 9.3.9 Indonesia
  • 9.3.10 Thailand
  • 9.3.11 Malaysia
  • 9.3.12 Philippines

10 Latin America

• 10.1 Latin America Shingles Vaccine Market Size by Type
  • 10.1.1 Latin America Shingles Vaccine Sales by Type (2017-2028)
  • 10.1.2 Latin America Shingles Vaccine Revenue by Type (2017-2028)
• 10.2 Latin America Shingles Vaccine Market Size by Application
  • 10.2.1 Latin America Shingles Vaccine Sales by Application (2017-2028)
  • 10.2.2 Latin America Shingles Vaccine Revenue by Application (2017-2028)
• 10.3 Latin America Shingles Vaccine Sales by Country
  • 10.3.1 Latin America Shingles Vaccine Sales by Country (2017-2028)
  • 10.3.2 Latin America Shingles Vaccine Revenue by Country (2017-2028)
  • 10.3.3 Mexico
  • 10.3.4 Brazil
  • 10.3.5 Argentina

11 Middle East and Africa

• 11.1 Middle East and Africa Shingles Vaccine Market Size by Type
  • 11.1.1 Middle East and Africa Shingles Vaccine Sales by Type (2017-2028)
  • 11.1.2 Middle East and Africa Shingles Vaccine Revenue by Type (2017-2028)
• 11.2 Middle East and Africa Shingles Vaccine Market Size by Application
  • 11.2.1 Middle East and Africa Shingles Vaccine Sales by Application (2017-2028)
  • 11.2.2 Middle East and Africa Shingles Vaccine Revenue by Application (2017-2028)
• 11.3 Middle East and Africa Shingles Vaccine Sales by Country
  • 11.3.1 Middle East and Africa Shingles Vaccine Sales by Country (2017-2028)
  • 11.3.2 Middle East and Africa Shingles Vaccine Revenue by Country (2017-2028)
  • 11.3.3 Turkey
  • 11.3.4 Saudi Arabia
  • 11.3.5 U.A.E

12 Corporate Profiles

• 12.1 Merck
  • 12.1.1 Merck Corporation Information
  • 12.1.2 Merck Overview
  • 12.1.3 Merck Shingles Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 12.1.4 Merck Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.1.5 Merck Recent Developments
• 12.2 GlaxoSmithKline
  • 12.2.1 GlaxoSmithKline Corporation Information
  • 12.2.2 GlaxoSmithKline Overview
  • 12.2.3 GlaxoSmithKline Shingles Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 12.2.4 GlaxoSmithKline Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.2.5 GlaxoSmithKline Recent Developments

13 Industry Chain and Sales Channels Analysis

• 13.1 Shingles Vaccine Industry Chain Analysis
• 13.2 Shingles Vaccine Key Raw Materials
  • 13.2.1 Key Raw Materials
  • 13.2.2 Raw Materials Key Suppliers
• 13.3 Shingles Vaccine Production Mode & Process
• 13.4 Shingles Vaccine Sales and Marketing
  • 13.4.1 Shingles Vaccine Sales Channels
  • 13.4.2 Shingles Vaccine Distributors
• 13.5 Shingles Vaccine Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 14.1 Shingles Vaccine Industry Trends
• 14.2 Shingles Vaccine Market Drivers
• 14.3 Shingles Vaccine Market Challenges
• 14.4 Shingles Vaccine Market Restraints

15 Key Finding in The Global Shingles Vaccine Study

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details
• 16.3 Disclaimer

• Table 1. Global Shingles Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Zostavax
• Table 3. Major Manufacturers of Shingrix
• Table 4. Global Shingles Vaccine Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
• Table 5. Global Shingles Vaccine Production by Region: 2017 VS 2021 VS 2028 (K Doses)
• Table 6. Global Shingles Vaccine Production by Region (2017-2022) & (K Doses)
• Table 7. Global Shingles Vaccine Production Market Share by Region (2017-2022)
• Table 8. Global Shingles Vaccine Production by Region (2023-2028) & (K Doses)
• Table 9. Global Shingles Vaccine Production Market Share by Region (2023-2028)
• Table 10. Global Shingles Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 11. Global Shingles Vaccine Sales by Region (2017-2022) & (K Doses)
• Table 12. Global Shingles Vaccine Sales Market Share by Region (2017-2022)
• Table 13. Global Shingles Vaccine Sales by Region (2023-2028) & (K Doses)
• Table 14. Global Shingles Vaccine Sales Market Share by Region (2023-2028)
• Table 15. Global Shingles Vaccine Revenue by Region (2017-2022) & (US$ Million)
• Table 16. Global Shingles Vaccine Revenue Market Share by Region (2017-2022)
• Table 17. Global Shingles Vaccine Revenue by Region (2023-2028) & (US$ Million)
• Table 18. Global Shingles Vaccine Revenue Market Share by Region (2023-2028)
• Table 19. Global Shingles Vaccine Production Capacity by Manufacturers (2017-2022) & (K Doses)
• Table 20. Global Shingles Vaccine Capacity Market Share by Manufacturers (2017-2022)
• Table 21. Global Shingles Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
• Table 22. Global Shingles Vaccine Sales Market Share by Manufacturers (2017-2022)
• Table 23. Global Shingles Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 24. Global Shingles Vaccine Revenue Share by Manufacturers (2017-2022)
• Table 25. Shingles Vaccine Price by Manufacturers 2017-2022 (USD/Dose)
• Table 26. Global Shingles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 27. Global Shingles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shingles Vaccine as of 2021)
• Table 28. Shingles Vaccine Manufacturing Base Distribution and Headquarters
• Table 29. Manufacturers Shingles Vaccine Product Offered
• Table 30. Date of Manufacturers Enter into Shingles Vaccine Market
• Table 31. Mergers & Acquisitions, Expansion Plans
• Table 32. Global Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
• Table 33. Global Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
• Table 34. Global Shingles Vaccine Sales Share by Type (2017-2022)
• Table 35. Global Shingles Vaccine Sales Share by Type (2023-2028)
• Table 36. Global Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 37. Global Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 38. Global Shingles Vaccine Revenue Share by Type (2017-2022)
• Table 39. Global Shingles Vaccine Revenue Share by Type (2023-2028)
• Table 40. Shingles Vaccine Price by Type (2017-2022) & (USD/Dose)
• Table 41. Global Shingles Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
• Table 42. Global Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
• Table 43. Global Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
• Table 44. Global Shingles Vaccine Sales Share by Application (2017-2022)
• Table 45. Global Shingles Vaccine Sales Share by Application (2023-2028)
• Table 46. Global Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 47. Global Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 48. Global Shingles Vaccine Revenue Share by Application (2017-2022)
• Table 49. Global Shingles Vaccine Revenue Share by Application (2023-2028)
• Table 50. Shingles Vaccine Price by Application (2017-2022) & (USD/Dose)
• Table 51. Global Shingles Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
• Table 52. North America Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
• Table 53. North America Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
• Table 54. North America Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 55. North America Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 56. North America Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
• Table 57. North America Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
• Table 58. North America Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 59. North America Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 60. North America Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
• Table 61. North America Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
• Table 62. North America Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 63. North America Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 64. Europe Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
• Table 65. Europe Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
• Table 66. Europe Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 67. Europe Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 68. Europe Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
• Table 69. Europe Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
• Table 70. Europe Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 71. Europe Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 72. Europe Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
• Table 73. Europe Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
• Table 74. Europe Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 75. Europe Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 76. Asia Pacific Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
• Table 77. Asia Pacific Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
• Table 78. Asia Pacific Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 79. Asia Pacific Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 80. Asia Pacific Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
• Table 81. Asia Pacific Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
• Table 82. Asia Pacific Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 83. Asia Pacific Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 84. Asia Pacific Shingles Vaccine Sales by Region (2017-2022) & (K Doses)
• Table 85. Asia Pacific Shingles Vaccine Sales by Region (2023-2028) & (K Doses)
• Table 86. Asia Pacific Shingles Vaccine Revenue by Region (2017-2022) & (US$ Million)
• Table 87. Asia Pacific Shingles Vaccine Revenue by Region (2023-2028) & (US$ Million)
• Table 88. Latin America Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
• Table 89. Latin America Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
• Table 90. Latin America Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 91. Latin America Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 92. Latin America Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
• Table 93. Latin America Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
• Table 94. Latin America Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 95. Latin America Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 96. Latin America Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
• Table 97. Latin America Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
• Table 98. Latin America Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 99. Latin America Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 100. Middle East and Africa Shingles Vaccine Sales by Type (2017-2022) & (K Doses)
• Table 101. Middle East and Africa Shingles Vaccine Sales by Type (2023-2028) & (K Doses)
• Table 102. Middle East and Africa Shingles Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 103. Middle East and Africa Shingles Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 104. Middle East and Africa Shingles Vaccine Sales by Application (2017-2022) & (K Doses)
• Table 105. Middle East and Africa Shingles Vaccine Sales by Application (2023-2028) & (K Doses)
• Table 106. Middle East and Africa Shingles Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 107. Middle East and Africa Shingles Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 108. Middle East and Africa Shingles Vaccine Sales by Country (2017-2022) & (K Doses)
• Table 109. Middle East and Africa Shingles Vaccine Sales by Country (2023-2028) & (K Doses)
• Table 110. Middle East and Africa Shingles Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 111. Middle East and Africa Shingles Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 112. Merck Corporation Information
• Table 113. Merck Description and Major Businesses
• Table 114. Merck Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 115. Merck Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Merck Recent Development
• Table 117. GlaxoSmithKline Corporation Information
• Table 118. GlaxoSmithKline Description and Major Businesses
• Table 119. GlaxoSmithKline Shingles Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 120. GlaxoSmithKline Shingles Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. GlaxoSmithKline Recent Development
• Table 122. Key Raw Materials Lists
• Table 123. Raw Materials Key Suppliers Lists
• Table 124. Shingles Vaccine Distributors List
• Table 125. Shingles Vaccine Customers List
• Table 126. Shingles Vaccine Market Trends
• Table 127. Shingles Vaccine Market Drivers
• Table 128. Shingles Vaccine Market Challenges
• Table 129. Shingles Vaccine Market Restraints
• Table 130. Research Programs/Design for This Report
• Table 131. Key Data Information from Secondary Sources
• Table 132. Key Data Information from Primary Sources

List of Figures

• Figure 1. Shingles Vaccine Product Picture
• Figure 2. Global Shingles Vaccine Market Share by Type in 2021 & 2028
• Figure 3. Zostavax Product Picture
• Figure 4. Shingrix Product Picture
• Figure 5. Global Shingles Vaccine Market Share by Application in 2021 & 2028
• Figure 6. Under 50 Years Old
• Figure 7. 50-60 Years Old
• Figure 8. 60-70 Years Old
• Figure 9. Above 70 Years Old
• Figure 10. Shingles Vaccine Report Years Considered
• Figure 11. Global Shingles Vaccine Capacity, Production and Utilization (2017-2028) & (K Doses)
• Figure 12. Global Shingles Vaccine Production Market Share by Region in Percentage: 2021 Versus 2028
• Figure 13. Global Shingles Vaccine Production Market Share by Region (2017-2022)
• Figure 14. Global Shingles Vaccine Production Market Share by Region (2023-2028)
• Figure 15. Shingles Vaccine Production Growth Rate in North America (2017-2028) & (K Doses)
• Figure 16. Shingles Vaccine Production Growth Rate in Europe (2017-2028) & (K Doses)
• Figure 17. Shingles Vaccine Production Growth Rate in China (2017-2028) & (K Doses)
• Figure 18. Shingles Vaccine Production Growth Rate in Japan (2017-2028) & (K Doses)
• Figure 19. Global Shingles Vaccine Sales 2017-2028 (K Doses)
• Figure 20. Global Shingles Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 21. Global Shingles Vaccine Revenue 2017-2028 (US$ Million)
• Figure 22. Global Shingles Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 23. Global Shingles Vaccine Sales Market Share by Region (2017-2022)
• Figure 24. Global Shingles Vaccine Sales Market Share by Region (2023-2028)
• Figure 25. North America Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
• Figure 26. North America Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. Europe Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
• Figure 28. Europe Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 29. Asia-Pacific Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
• Figure 30. Asia-Pacific Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 31. Latin America Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
• Figure 32. Latin America Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 33. Middle East & Africa Shingles Vaccine Sales YoY (2017-2028) & (K Doses)
• Figure 34. Middle East & Africa Shingles Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 35. The Shingles Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 36. The Top 5 and 10 Largest Manufacturers of Shingles Vaccine in the World: Market Share by Shingles Vaccine Revenue in 2021
• Figure 37. Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 38. Global Shingles Vaccine Sales Market Share by Type (2017-2028)
• Figure 39. Global Shingles Vaccine Revenue Market Share by Type (2017-2028)
• Figure 40. Global Shingles Vaccine Sales Market Share by Application (2017-2028)
• Figure 41. Global Shingles Vaccine Revenue Market Share by Application (2017-2028)
• Figure 42. North America Shingles Vaccine Sales Market Share by Type (2017-2028)
• Figure 43. North America Shingles Vaccine Revenue Market Share by Type (2017-2028)
• Figure 44. North America Shingles Vaccine Sales Market Share by Application (2017-2028)
• Figure 45. North America Shingles Vaccine Revenue Market Share by Application (2017-2028)
• Figure 46. North America Shingles Vaccine Sales Share by Country (2017-2028)
• Figure 47. North America Shingles Vaccine Revenue Share by Country (2017-2028)
• Figure 48. U.S. Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 49. Canada Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 50. Europe Shingles Vaccine Sales Market Share by Type (2017-2028)
• Figure 51. Europe Shingles Vaccine Revenue Market Share by Type (2017-2028)
• Figure 52. Europe Shingles Vaccine Sales Market Share by Application (2017-2028)
• Figure 53. Europe Shingles Vaccine Revenue Market Share by Application (2017-2028)
• Figure 54. Europe Shingles Vaccine Sales Share by Country (2017-2028)
• Figure 55. Europe Shingles Vaccine Revenue Share by Country (2017-2028)
• Figure 56. Germany Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 57. France Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 58. U.K. Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 59. Italy Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 60. Russia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 61. Asia Pacific Shingles Vaccine Sales Market Share by Type (2017-2028)
• Figure 62. Asia Pacific Shingles Vaccine Revenue Market Share by Type (2017-2028)
• Figure 63. Asia Pacific Shingles Vaccine Sales Market Share by Application (2017-2028)
• Figure 64. Asia Pacific Shingles Vaccine Revenue Market Share by Application (2017-2028)
• Figure 65. Asia Pacific Shingles Vaccine Sales Share by Region (2017-2028)
• Figure 66. Asia Pacific Shingles Vaccine Revenue Share by Region (2017-2028)
• Figure 67. China Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 68. Japan Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 69. South Korea Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 70. India Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 71. Australia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 72. Taiwan Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 73. Indonesia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 74. Thailand Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 75. Malaysia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 76. Philippines Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 77. Latin America Shingles Vaccine Sales Market Share by Type (2017-2028)
• Figure 78. Latin America Shingles Vaccine Revenue Market Share by Type (2017-2028)
• Figure 79. Latin America Shingles Vaccine Sales Market Share by Application (2017-2028)
• Figure 80. Latin America Shingles Vaccine Revenue Market Share by Application (2017-2028)
• Figure 81. Latin America Shingles Vaccine Sales Share by Country (2017-2028)
• Figure 82. Latin America Shingles Vaccine Revenue Share by Country (2017-2028)
• Figure 83. Mexico Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 84. Brazil Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 85. Argentina Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 86. Middle East and Africa Shingles Vaccine Sales Market Share by Type (2017-2028)
• Figure 87. Middle East and Africa Shingles Vaccine Revenue Market Share by Type (2017-2028)
• Figure 88. Middle East and Africa Shingles Vaccine Sales Market Share by Application (2017-2028)
• Figure 89. Middle East and Africa Shingles Vaccine Revenue Market Share by Application (2017-2028)
• Figure 90. Middle East and Africa Shingles Vaccine Sales Share by Country (2017-2028)
• Figure 91. Middle East and Africa Shingles Vaccine Revenue Share by Country (2017-2028)
• Figure 92. Turkey Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 93. Saudi Arabia Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 94. U.A.E Shingles Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 95. Shingles Vaccine Value Chain
• Figure 96. Shingles Vaccine Production Process
• Figure 97. Channels of Distribution
• Figure 98. Distributors Profiles
• Figure 99. Bottom-up and Top-down Approaches for This Report
• Figure 100. Data Triangulation
• Figure 101. Key Executives Interviewed